Wednesday, January 11, 2012 5:31:02 PM
i'm holding for at least the Q4 from 2011 to be released in coming weeks. their last two filings showed that they've made significant progress in reducing losses.
coupled with the most recent cutbacks with some asset sales and getting rid of kazaa, one can only imagine what such positive reports would do for the PPS.
indeed, this is still a stock with millions in quarterly revenues but a market cap that is merely a fraction of that.
the fact is that this is grossly undervalued, period. as much as it hurts to look at this on a day to day basis, this won't be trading at these low levels in a couple of weeks.
coupled with the most recent cutbacks with some asset sales and getting rid of kazaa, one can only imagine what such positive reports would do for the PPS.
indeed, this is still a stock with millions in quarterly revenues but a market cap that is merely a fraction of that.
the fact is that this is grossly undervalued, period. as much as it hurts to look at this on a day to day basis, this won't be trading at these low levels in a couple of weeks.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
